Manish K. Jain
Expertise in
20
conditions

Dr. Manish K. Jain

Rheumatology
1945 W. Wilson Ave., Suite 100, 
Chicago, IL 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
20
conditions
1945 W. Wilson Ave., Suite 100, 
Chicago, IL 

Overview

Manish Jain, MD, is an independent rheumatologist at Ascension Illinois in Chicago, near Chicago, Illinois. Dr. Jain diagnoses and treats autoinflammatory and autoimmune diseases such as carpal tunnel syndrome, gout, lupus, psoriasis and rheumatoid arthritis. Dr. Jain specializes in advanced treatments, including ultrasound-guided injections and medication management. Dr. Jain listens to understand your health needs, then works with you to create a personalized care plan.

Dr. Jain is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Undifferentiated Connective Tissue Disease (UCTD), Psoriasis, Vitrectomy, and Gallbladder Removal.

Dr. Jain is board certified in American Board Of Internal Medicine, The American Board Of Internal Medicine - Rheumatology, and The American Board Of Internal Medicine - Internal Medicine. He is actively involved in clinical research, co-authoring 141 peer reviewed articles and participating in 7 clinical trials. Dr. Jain is currently accepting new patients.

Specialties

Rheumatology

Licenses

Student in an Organized Health Care Education/Training Program in NY

Board Certifications

American Board Of Internal Medicine
The American Board Of Internal Medicine - Rheumatology
The American Board Of Internal Medicine - Internal Medicine

Hospital Affiliations

Ascension Saint Joseph - Chicago
Saint Francis Hospital-Evanston
Johnson Memorial Hospital
Swedish Hospital
Northshore University Healthsystem - Evanston Hospital
Presence Saint Joseph Hospital - Chicago

Languages Spoken

English
Hindi
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Northside Rheumatology, LLC
1945 W. Wilson Ave., Suite 100, Chicago, IL 60640

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
Enrollment Status: Terminated
Publish Date: October 20, 2025
Intervention Type: Drug
Study Drug: Casirivimab+Imdevimab
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
Enrollment Status: Completed
Publish Date: July 28, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 1, Multi-Center, Open-Label, Safety and Tolerability Study of Intravenous Administration of ST266 in Subjects With Confirmed COVID-19 Infection
A Phase 1, Multi-Center, Open-Label, Safety and Tolerability Study of Intravenous Administration of ST266 in Subjects With Confirmed COVID-19 Infection
Enrollment Status: Completed
Publish Date: June 15, 2022
Intervention Type: Biological
Study Drug: ST266
Study Phase: Phase 1
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood
Enrollment Status: Completed
Publish Date: June 18, 2021
Intervention Type: Diagnostic test
View 6 Less Clinical Trials

141 Total Publications

Lumbosacral Spinal Tuberculosis: Clinical Spectrum, Diagnostic Challenges, and Short-Term Management Outcomes in an Elderly Cohort.
Lumbosacral Spinal Tuberculosis: Clinical Spectrum, Diagnostic Challenges, and Short-Term Management Outcomes in an Elderly Cohort.
Journal: Cureus
Published: June 22, 2026
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required
Before you request

University Of Illinois Chicago Physician Group (Uicpg)

1801 W Taylor St, 
Chicago, IL 
 (6.6 miles away)
312-355-1700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nadera Sweiss is a Rheumatologist practicing medicine in Chicago, Illinois. Dr. Sweiss is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Sarcoidosis, Neurosarcoidosis, Rheumatoid Arthritis (RA), and Scleroderma. Dr. Sweiss is currently accepting new patients.

Expertise in
18
conditions
Dr. Robert S. Katz
Rheumatology
Expertise in
18
conditions
Dr. Robert S. Katz
Rheumatology
Referral may be required
Before you request

Office

1725 W Harrison St Ste 365, 
Chicago, IL 
 (5.9 miles away)
312-942-2159
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Katz is a Rheumatologist practicing medicine in Chicago, Illinois. Dr. Katz is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Fibromyalgia, Arthritis, Rheumatoid Arthritis (RA), and Postmenopausal Osteoporosis. Dr. Katz is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required
Before you request

University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (12.7 miles away)
773-702-6885
Languages Spoken:
English
Accepting New Patients

Timothy Niewold is a Rheumatologist practicing medicine in Chicago, Illinois. Dr. Niewold is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Dermatomyositis, Polymyositis, and Lupus Nephritis. Dr. Niewold is currently accepting new patients.

Frequently Asked Questions about Dr. Manish K. Jain

How do I make an appointment with Dr. Manish K. Jain?

You can book an appointment with Dr. Manish K. Jain by calling their office at 773-769-9040. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Manish K. Jain a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Manish K. Jain is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Manish K. Jain specialize in?

While Dr. Manish K. Jain is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Undifferentiated Connective Tissue Disease (UCTD), and Psoriasis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Manish K. Jain participate in research or clinical trials?

Yes. Dr. Manish K. Jain has published 141 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Manish K. Jain's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Manish K. Jain accept my insurance?

Dr. Manish K. Jain accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 773-769-9040 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jain's expertise for a condition
ConditionClose
    View All 19 Advanced Conditions
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile